Coupling reagents convert a protected amino acid into a species reactive enough to form an amide bond quickly, and the choice determines both yield and racemisation risk.
Key Takeaways
- Carboxylic acids do not form amides spontaneously under mild conditions, so the C-terminus must be activated.
- HBTU, HATU, and PyBOP give fast, efficient couplings with low racemisation when used with a tertiary base.
- Routine sequences succeed with DIC and Oxyma.
What the reagent does
Carboxylic acids do not form amides spontaneously under mild conditions, so the C-terminus must be activated. The reagent converts it to an activated ester or similar intermediate that the incoming amine attacks readily.
Carbodiimides and additives
DCC and DIC are inexpensive and effective but promote racemisation and, in DCC’s case, leave a poorly soluble urea byproduct. Adding HOBt or Oxyma suppresses racemisation and is standard practice rather than optional refinement.
For related mechanism work, see solid-phase peptide synthesis.
Uronium and phosphonium reagents
HBTU, HATU, and PyBOP give fast, efficient couplings with low racemisation when used with a tertiary base. HATU is generally the most effective for difficult couplings, and the cost difference is small relative to the value of a successful synthesis.
Racemisation control
Histidine, cysteine, and serine are the residues most prone to racemisation, which is difficult to detect because the epimer often co-elutes. Pre-activation time, base choice, and temperature all influence the outcome.
Matching reagent to problem
Routine sequences succeed with DIC and Oxyma. Difficult couplings justify HATU, and when aggregation rather than activation is the obstacle, no reagent will help without a change in solvent, temperature, or resin loading.
Experimental Conditions and Practical Setup
Activation is performed with a slight excess of reagent and base in DMF, with a short pre-activation period before the resin is added. Pre-activation time is kept controlled because extended activation increases racemisation, and moisture is excluded since it consumes the activated species and lowers the effective excess.
Coupling reagent selection
| Reagent | Best for | Caution |
|---|---|---|
| DIC with Oxyma | Routine couplings | Urea solubility on scale |
| HATU | Difficult or hindered couplings | Cost, and racemisation if over-activated |
| HBTU | General purpose | Less effective on hindered residues |
| PyBOP | Where uronium reagents are unsuitable | Phosphonium byproducts |
Practical Notes for the Bench
- Use HOBt or Oxyma with carbodiimides, not as an optional extra.
- Watch racemisation particularly with histidine, cysteine, and serine.
- Change solvent or loading when aggregation, not activation, is the barrier.
Frequently Asked Questions
Which coupling reagent should I default to?
DIC with Oxyma for routine sequences; HATU when a coupling is proving difficult and the cost is justified.
Why add HOBt or Oxyma?
They form an active ester intermediate that suppresses racemisation during activation.
Can a better reagent fix a failed synthesis?
Only if activation was the problem. If the chain is aggregating on the resin, reagent choice will not resolve it.
Why not always use the most powerful reagent?
Because cost rises and racemisation risk increases. More importantly, if the failure is on-resin aggregation rather than activation, no reagent will help without changing solvent, temperature, or loading.
Related Reading
- solid-phase peptide synthesis
- peptide modifications labelling
- difficult peptide sequences
- ghrelin peptide hormone
- peptide lyophilisation
References & Further Reading
- Cao S et al. β-Acyloxyl alkenyl amide synthesis via multiple defluorination: α-Trifluoromethyl ketone-amine as synergystic peptide coupling reagent. Sci Adv. 2025. PubMed 41134897
- Hu L et al. Ynamide Coupling Reagents: Origin and Advances. Acc Chem Res. 2024. PubMed 38452397
- Hu L et al. Ynamides as Racemization-Free Coupling Reagents for Amide and Peptide Synthesis. J Am Chem Soc. 2016. PubMed 27685176
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- Peptide research collection at Nature
The notes below reflect common laboratory practice and open literature. They are not clinical recommendations, and peptides discussed are research materials unless stated otherwise.
Reviewed by Dr. Elena Marchetti, Peptide Chemistry & Analytical Characterization.